Generic drugmaker Granules India is foraying into the peptide segment and contract development and manufacturing organisation (CDMO) business with a ₹192.5 crore (CHF 20 million) acquisition of Swiss ...

Hims & Hers Health Inc. has acquired a California-based manufacturing facility to expand its range of peptide treatments, ...

Granules India has purchased Senn Chemicals AG, a Swiss CDMO firm specializing in peptide therapeutics, for CHF 20 million.

The startup is expanding its services less than one year after it started offering compounded GLP-1 weight loss drugs.

Kate Farms, the #1 recommended plant-based brand*, is thrilled to introduce a new organic, natural strawberry flavor for ...

Peptide therapy enhances targeted medicine, utilizing specific peptides for effective treatment of cancer, metabolic disorders, and neurodegenerative diseases.

Many peptide medications like glucagon-like peptide-1 (GLP-1) receptor agonists were initially developed to treat type 2 diabetes. One unexpected side effect of these drugs is weight loss.

Hims & Hers Health, Inc., the leading health and wellness platform, today announced an acquisition that will further verticalize the company’s long-term ability to deliver personalized medications.

Hims & Hers Health acquired a peptide facility to strengthen its U.S. supply chain and meet demand for personalized ...

I left behind dark wads of hair in the shower, sink, bed, and even in my daughter’s mighty little fists. “You gotta stop ...

For its entry into fast growing peptide segment and strengthen its CDMO biz ...

Reduce Inflammation: Peptides with anti-inflammatory properties soothe redness and irritation, making them ideal for ...